Biotech Investors & VC Firms in North America

272 firms in this list, with a median first check of $500K. 65 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
MA Magnetic Ventures CAJSUEJW7 people · Leads rounds	88🔒	Boston	US	Seed–Series A	$1M – $6M	+ Add to CRM
IN Intermediate Capital Group BDAIASAL16 people	88🔒	London	GB	Growth–Late Stage	$5M – $50M	+ Add to CRM
FO Fountain Healthcare Partners AKMREPJL8 people · Leads rounds	88🔒	Dublin	IE	Seed–Series B	$10.8M – $16.2M	+ Add to CRM
WE WELL Ventures HSAJASAK16 people	88🔒	Vancouver	CA	Seed–Growth	—	+ Add to CRM
WO Woori Technology Investment JHJLDUCK19 people	88🔒	Seoul	KR	—	—	+ Add to CRM
EI EIR Ventures AHMPSCLB10 people · Leads rounds	88🔒	Stockholm	SE	Seed–Growth	—	+ Add to CRM
AP Apex Innovative Investments Ventures MHADASSC9 people	88🔒	Vancouver	CA	Pre-Seed–Series A	$250K	+ Add to CRM
H. H.I.G. HealthBridge Partners SMTTBSBR9 people	88🔒	Miami	US	Growth	$5M – $40M	+ Add to CRM
FO Forbion DHMBWJCI16 people	88🔒	Naarden	NL	Pre-Seed–Late Stage	—	+ Add to CRM
HI Highline Beta BYMDDBJM18 people	88🔒	Toronto	CA	Pre-Seed–Growth	—	+ Add to CRM
CR Cross-Border Impact Ventures ATDPMDIG12 people	88🔒	Toronto	CA	Series A–Series B	$2M – $10M	+ Add to CRM
VS VSC Ventures JKVCASEG9 people	88🔒	San Francisco	US	Pre-Seed–Series A	$500K – $750K	+ Add to CRM
RO Rockies Venture Club Leads rounds	88🔒	Denver	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
SU SustainVC SLACECJD6 people · Follows rounds	88🔒	Boston	US	Seed–Series A	$500K – $1M	+ Add to CRM
WA WA4STEAM BOCPEAID6 people	88🔒	Barcelona	ES	Pre-Seed–Series A	—	+ Add to CRM
CR Criteria Bio Ventures PCACSCSC8 people · Leads rounds	88🔒	Barcelona	ES	Seed–Late Stage	—	+ Add to CRM
NE Neva Sgr. LRMCLNAG8 people	88🔒	Turin	IT	Series A–Growth	—	+ Add to CRM
NE New Rhein Healthcare Investors, LLC NGIGSSAA14 people	88🔒	Philadelphia	US	Series A–Late Stage	—	+ Add to CRM
TR Triventures DMMGDGLL11 people	88🔒	Herzliya	IL	Pre-Seed–Series A	$3M	+ Add to CRM
BR Braven BWJHLEWA17 people	88🔒	New York	US	Seed–Series B	—	+ Add to CRM
BA Barrel Ventures CCNCMKRS6 people	88🔒	Evanston	US	Seed	—	+ Add to CRM
GE Genesys Capital DLKHJSJW9 people	88🔒	Toronto	CA	Seed–Series B	$730K – $3.6M	+ Add to CRM
IN InHealth Ventures IBBELBRB5 people · Leads rounds	88🔒	London	GB	Pre-Seed–Series A	$500K – $3M	+ Add to CRM
TE Tech Council Ventures JGMKSSAP7 people · Leads rounds	88🔒	Summit	US	Seed–Series B	$500K – $3M	+ Add to CRM

Magnetic Ventures

BostonSeed–Series A$1M – $6M

CAJSUEJW7 people

Intermediate Capital Group

LondonGrowth–Late Stage$5M – $50M

BDAIASAL16 people

Fountain Healthcare Partners

DublinSeed–Series B$10.8M – $16.2M

AKMREPJL8 people

WELL Ventures

VancouverSeed–Growth

HSAJASAK16 people

Woori Technology Investment

Seoul

JHJLDUCK19 people

EIR Ventures

StockholmSeed–Growth

AHMPSCLB10 people

Apex Innovative Investments Ventures

VancouverPre-Seed–Series A$250K

MHADASSC9 people

H.I.G. HealthBridge Partners

MiamiGrowth$5M – $40M

SMTTBSBR9 people

Forbion

NaardenPre-Seed–Late Stage

DHMBWJCI16 people

Highline Beta

TorontoPre-Seed–Growth

BYMDDBJM18 people

Cross-Border Impact Ventures

TorontoSeries A–Series B$2M – $10M

ATDPMDIG12 people

VSC Ventures

San FranciscoPre-Seed–Series A$500K – $750K

JKVCASEG9 people

Rockies Venture Club

DenverPre-Seed–Series A$100K – $500K

SustainVC

BostonSeed–Series A$500K – $1M

SLACECJD6 people

WA4STEAM

BarcelonaPre-Seed–Series A

BOCPEAID6 people

Criteria Bio Ventures

BarcelonaSeed–Late Stage

PCACSCSC8 people

Neva Sgr.

TurinSeries A–Growth

LRMCLNAG8 people

New Rhein Healthcare Investors, LLC

PhiladelphiaSeries A–Late Stage

NGIGSSAA14 people

Triventures

HerzliyaPre-Seed–Series A$3M

DMMGDGLL11 people

Braven

New YorkSeed–Series B

BWJHLEWA17 people

Barrel Ventures

EvanstonSeed

CCNCMKRS6 people

Genesys Capital

TorontoSeed–Series B$730K – $3.6M

DLKHJSJW9 people

InHealth Ventures

LondonPre-Seed–Series A$500K – $3M

IBBELBRB5 people

Tech Council Ventures

SummitSeed–Series B$500K – $3M

JGMKSSAP7 people

Data sourced from public filings and firms' own websites — see our methodology.